Sensorion SA (ALSEN) fair value: what the stock is really worth
As of Nov 19, 2026: fair value (intrinsic value) of Sensorion SA stock €6.94, price €7.62, that is 9.0% below the price, quality 38 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Sensorion SA
ALSEN · PAThe stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range €5.64 – €109.00 · fair‑value band €5.20 – €8.67 · the €7.62 price screens above the €6.94 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Sensorion is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Sensorion SA, a biotechnology company, engages in the development of novel therapies to restore, treat, and prevent hearing loss disorders in France.
Show moreShow less
The company develops SENS-501, a dual AAV vector gene therapy development product for restoring hearing in patients with mutations in OTOF gene in Phase 1/2 clinical trials; and SENS-601, a candidate for the treatment of hearing loss caused by mutations of the GJB2 gene in preclinical studies.
It is also developing SENS-40, a small molecule in Phase 2b clinical trials to treat sudden sensorineural hearing loss; prevention of residual hearing loss following cochlear implantation in Phase 2a clinical trials; and prevention of cisplatin-induced ototoxicity in Phase 2a clinical trials.
The company was incorporated in 2009 and is headquartered in Montpellier, France.
Stock analysis
Sensorion SA (ALSEN) currently trades at €7.62, while our estimate is €6.94, so the stock looks roughly fairly valued today (gap 9.9%).
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: €5.20 (bear) to €8.67 (bull), the price of €7.62 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Sensorion SA reported revenue of €0 in FY2025 versus €4.3M in FY2021. Reported net income was −€29.4M in FY2025.
Key figures
Market cap €79.4M Micro · P/S ratio 14.6 · EPS (TTM) €−4.65 · Return on equity −49.3% · Return on assets (EBIT) −49.6% (5-year average) · Operating margin −803% · Revenue (TTM) €6.2M · Revenue growth (YoY) +14.7%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).
What moves the price
The share trades about 78% below its 52-week high and 35% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −9%, ALSEN screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch ALSEN, get fair value alerts →
Compare Sensorion SA with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 851 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Net margin by industry
- P/B ratio by industry
- Stock screener with 62 metrics
- Undervalued stocks: French Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $945.53 | $1,275 | +35% | vs ALSEN |
| Vertex Pharmaceuticals Incorporated VRTX | $536.45 | $587.62 | +10% | vs ALSEN |
| Samsung Biologics Co 207940 | 1,375,000 KRW | 1,502,600 KRW | +9% | vs ALSEN |
| argenx SE ARGX | $941.25 | $908.40 | −3% | vs ALSEN |
| CSL Limited CSL | A$199.85 | A$186.49 | −7% | vs ALSEN |
| Moderna, Inc MRNA | $196.79 | $135.64 | −31% | vs ALSEN |
| BeOne Medicines AG 6160 | HK$242.60 | HK$152.92 | −37% | vs ALSEN |
| Revolution Medicines, Inc RVMD | $159.82 | $83.12 | −48% | vs ALSEN |
| Celltrion, Inc 068270 | 215,000 KRW | 74,945 KRW | −65% | vs ALSEN |
| Royalty Pharma plc RPRX | $68.67 | $19.01 | −72% | vs ALSEN |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Sensorion SA (ALSEN) overvalued or undervalued?
What is the fair value of ALSEN?
What is the quality score of ALSEN?
What is the price target for Sensorion SA (ALSEN)?
What is the Sensorion SA stock forecast for 2026?
What is the revenue of Sensorion SA (ALSEN)?
What is the intrinsic value of Sensorion SA (ALSEN)?
Is Sensorion SA stock overvalued or undervalued in 2026?
Is fair value the same as the market price of ALSEN?
How much is Sensorion SA worth?
What do the bullish and bearish scenarios say about ALSEN?
How solid is the balance sheet of Sensorion SA (ALSEN)?
How far is ALSEN from its 52-week high?
Which stocks are comparable to Sensorion SA?
Is Sensorion SA stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Sensorion SA (ALSEN)?
What should I pay attention to with Sensorion SA right now?
Key figures of Sensorion SA
How large is the market capitalisation of Sensorion SA (ALSEN)?
What is the P/S ratio of Sensorion SA (ALSEN)?
What are the earnings per share of Sensorion SA (ALSEN)?
What is the return on equity of Sensorion SA (ALSEN)?
What is the EBIT return on assets of Sensorion SA (ALSEN)?
What is the operating margin of Sensorion SA (ALSEN)?
How fast is revenue growing at Sensorion SA (ALSEN)?
How much free cash flow does Sensorion SA (ALSEN) generate?
How much net cash does Sensorion SA (ALSEN) hold?
Watch Sensorion SA in the live analysis
One click puts Sensorion SA on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.